tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Zegbeh Jallah, 153 are a BUY (96.84%), 5 are a HOLD (3.16%).
Analyst Zegbeh Jallah, currently employed at CAPITAL ONE, carries an average stock price target met ratio of 44.89% that have a potential upside of 41.29% achieved within 412 days. Previously, Zegbeh Jallah worked at ROTH MKM.
Zegbeh Jallah’s has documented 298 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 27-Dec-2023.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $8 was fulfilled within 5 days with a profit of $5.19 (184.7%) receiving and performance score of 369.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2015
3 years 11 months 10 days ago
(25-Oct-2022)
0/10 (0%)
$13.99 (348.88%)
Hold Since 25-Oct-2022
$0.4
$0.01 (2.56%)
3 years 11 months 10 days ago
(25-Oct-2022)
1/1 (100%)
$0.01 (2.56%)
2
Buy Since 09-Feb-2017
$9
3 years 11 months 11 days ago
(24-Oct-2022)
1/3 (33.33%)
$7.17 (391.80%)
104
$0.34
$-0.05 (-12.82%)
3 years 11 months 11 days ago
(24-Oct-2022)
0/5 (0%)
$-0.05 (-12.82%)
Buy Since 11-Nov-2020
4 years 6 days ago
(29-Sep-2022)
0/2 (0%)
$6.72 (157.01%)
What Year was the first public recommendation made by Zegbeh Jallah?
